Nutriband Stock Quote NTRB - Stock Price, News, Charts, Message Board, Trades

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nutriband Inc (NTRB) Quote

Nutriband Inc (NTRB)

5.33

0.00

(0.00%)

Closed November 11 4:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

5.33

Bid

5.00

Ask

5.51

Volume

-

0.00 Day's Range 0.00

2.04 52 Week Range 9.595

Market Cap

Previous Close

5.33

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

34,445

Shares Outstanding

11,096,185

Dividend Yield

-

PE Ratio

-10.78

Earnings Per Share (EPS)

-0.49

Revenue

2.09M

Net Profit

-5.49M

Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically O... Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products. Show more

Sector

Ortho,prosth,surg Appl,suply

Industry

Ortho,prosth,surg Appl,suply

Website

nutriband.com

Headquarters

Las Vegas, Nevada, USA

Founded

-

Nutriband Inc is listed in the Ortho,prosth,surg Appl,suply sector of the NASDAQ with ticker NTRB. The last closing price for Nutriband was $5.33. Over the last year, Nutriband shares have traded in a share price range of $ 2.04 to $ 9.595.

Nutriband currently has 11,096,185 shares outstanding. The market capitalization of Nutriband is $59.14 million. Nutriband has a price to earnings ratio (PE ratio) of -10.78.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form EFFECT - Notice of Effectiveness

IBN Coverage Initiated for Nutriband Inc.

LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Nutriband Inc. (NASDAQ: NTRB), a pharmaceutical company with a specific focus on transdermal technologies, today announces it has...

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 8-K - Current report

Form SC 13D - General statement of acquisition of beneficial ownership

Form 8-K - Current report

Form 8-K - Current report

Form RW - Registration Withdrawal Request

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.61	-10.2693602694	5.94	5.95	5.1	16725	5.45283868	CS
4	-2.65	-33.2080200501	7.98	8.49	5.1	22513	6.4360397	CS
12	-0.37	-6.49122807018	5.7	8.49	3.75	34445	5.87996586	CS
26	1.81	51.4204545455	3.52	9.595	3.5	36249	5.94060478	CS
52	3.11	140.09009009	2.22	9.595	2.04	31497	5.01418664	CS
156	-0.27	-4.82142857143	5.6	12.18	1.53	265075	9.11759947	CS
260	-0.15	-2.73722627737	5.48	12.32	1.53	366360	9.12670189	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	$ 13.81 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 65.95 (0.00%)	0
AADIAadi Bioscience Inc	$ 2.125 (0.00%)	0
AACGATA Creativity Global	$ 1.04 (0.00%)	0
AALAmerican Airlines Group Inc	$ 13.81 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 65.95 (0.00%)	0
AADIAadi Bioscience Inc	$ 2.125 (0.00%)	0
AACGATA Creativity Global	$ 1.04 (0.00%)	0
AALAmerican Airlines Group Inc	$ 13.81 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 65.95 (0.00%)	0
AADIAadi Bioscience Inc	$ 2.125 (0.00%)	0
AACGATA Creativity Global	$ 1.04 (0.00%)	0

Seriously folks

Seriously folks 4 months ago

Must have been an interesting webinar….double the volume and down 8%.

Monksdream

Monksdream 4 months ago

NTRB new 52 week high

Seriously folks

Seriously folks 5 months ago

Now I’m told “it’ll “ happen 4q 2025….
More baloney….

Seriously folks

Seriously folks 5 months ago

Now I’m told “it’ll “ happen 4q 2025….
More baloney….

Seriously folks

Seriously folks 5 months ago

Typical ntrb day…

Awl416

Awl416 6 months ago

Monksdream

Monksdream 7 months ago

Wowser! I happen to agree with you.

ZigZag1

ZigZag1 7 months ago

It’s under $5 for a reason. Management is just using this company as a lifestyle paycheck.

Monksdream

Monksdream 7 months ago

Monksdream

Monksdream 7 months ago

glenn1919

glenn1919 7 months ago

NTRB................................https://stockcharts.com/h-sc/ui?s=NTRB&p=W&b=5&g=0&id=p86431144783

TrendTrade2016

TrendTrade2016 7 months ago

NTRB....MONSTER

TrendTrade2016

TrendTrade2016 7 months ago

NTRB...GAPPING INTO OPEN FOR THE SELL

glenn1919

glenn1919 8 months ago

NTRB...................................https://stockcharts.com/h-sc/ui?s=NTRB&p=W&b=5&g=0&id=p86431144783

TrendTrade2016

TrendTrade2016 8 months ago

NTRB....PRE TO OPEN BEAST

Inve$tor77

Inve$tor77 11 months ago

$NTRB 2.95. Nice buys.

ZigZag1

ZigZag1 1 year ago

This will be at a $1.50 by the end of the week. Management sure sold me on this one!

ZigZag1

ZigZag1 1 year ago

You’d think it price would reflect news like this. They have to get rid of the word “fentanyl”. It’s so toxic. It’s right up there with ephedrine and OxyContin.

Inve$tor77

Inve$tor77 1 year ago

Nice news!

https://www.accesswire.com/785775/nutriband-announces-issuance-of-us-patent-for-transdermal-abuse-deterrent-technology

ZigZag1

ZigZag1 1 year ago

I sold everything, I just check back from time to time. I think they are now just using their money for salaries. Their model has the word “fentanyl” in it which is about as toxic as the word “OxyContin”.

Seriously folks

Seriously folks 1 year ago

What’s going on with this stock?

McMagyar

McMagyar 1 year ago

Ollie Ollie unkenfraz

McMagyar

McMagyar 1 year ago

What lurks behind the curtain!

stock1ace1

stock1ace1 1 year ago

Registration withdraw low float

Monksdream

Monksdream 1 year ago

NTRB dead cat and the down trend resumes?

Inve$tor77

Inve$tor77 1 year ago

What’s with the huge selling? Seems like big ask

Inve$tor77

Inve$tor77 1 year ago

Bid and ask tight. Volume coming in.

Inve$tor77

Inve$tor77 1 year ago

Agreed. Once the selling stop perhaps it will rebound back .

ZigZag1

ZigZag1 1 year ago

It could. But being out of money is going to make things tough. They definitely need something good to happen for this to pop.

Inve$tor77

Inve$tor77 1 year ago

I’m not sure it’s going to hit that low before a nice bounce back. It’s still a low float stock.

ZigZag1

ZigZag1 1 year ago

I personally see it at $1. Their revenue comes from k tape that you can get off of Amazon for $5. Their hope is this fentanyl patch. But even if they get approval? I don’t see many Drs wanting to prescribe it, nor patients wanting it. Let’s put it this way; if a dr asked you if you wanted traditional pain meds or a fentanyl patch; what would you want?

Inve$tor77

Inve$tor77 1 year ago

Where’s bottom? Should be close for a bounce hopefully.

ZigZag1

ZigZag1 1 year ago

It’s like 7.5m outstanding, but now doing an offering of $4m with a market cap of $15m, just simply means they are out of money. This isn’t looking good. I just wish they would change the name to something like “drug deterrent patch” or something. Who would want to keep an investment in fentanyl? That’s a word right up there with OxyContin???

Inve$tor77

Inve$tor77 1 year ago

Wasn’t there an offering for $4 mill minus underwriting fees?
I don’t remember the volume being that high. Isn’t that around 1.5 million shares sold.

“Our common stock is traded on the NASDAQ Capital Market under the symbol “NTRB. On June 22, 2023, the last reported sale price of our common stock was $2.48 per share.”

ZigZag1

ZigZag1 1 year ago

Dang, they get a patent approved and now it’s tanking. This will give you an idea of how solid their model is.

ZigZag1

ZigZag1 1 year ago

Why so much volume today?

Inve$tor77

Inve$tor77 1 year ago

New 52 week lows geez. What’s going on?

Inve$tor77

Inve$tor77 1 year ago

$2.50s. Looking for a nice bounce possibly . Float is tiny

ZigZag1

ZigZag1 1 year ago

I’m not sure their model has the capability of meaningful good news. Anything with the fentanyl in it, proves to be an uphill battle.

Inve$tor77

Inve$tor77 1 year ago

With any good news or buying pressure this can take off nicely. Very thin float.

Inve$tor77

Inve$tor77 1 year ago

Nice bounce recovery from lows. When good news hits looking forward to a big climb. I saw they filed for a small offering a couple of weeks ago. I’m surprised they did it at this low price.

ZigZag1

ZigZag1 1 year ago

Yes they are. But I think it’s going to be an up-hill battle trying to get anything approved with the word “Fentanyl” in it. Talk about FDA scrutiny!

Inve$tor77

Inve$tor77 1 year ago

Does anyone know if they are still waiting on FDA approval ?

McMagyar

McMagyar 2 years ago

Seriously folks

Seriously folks 2 years ago

It looks like this might be turning around….

McMagyar

McMagyar 3 years ago

Entrepreneurial spirit isn’t dead
Nutriband full steam ahead

McMagyar

McMagyar 3 years ago

I don’t think market is giving the 3m agreement enough value.they may have a few surprises coming our way

Seriously folks

Seriously folks 3 years ago

Still heading the wrong direction!

Seriously folks

Seriously folks 3 years ago

What a disappointment……

StocksNcash

StocksNcash 3 years ago

I dumped it garbage

Delayed Upgrade Clock